EUVIMEDEUVIMED entdecken
Crossref

Loc646329 sponges miR-21 to reduce RAS/MAP kinase signaling pathway in oral squamous cell carcinoma (OSCC)

Akhtar Adereh, Parya Amini, Azadeh Fateh, Ferdos Faghihkhorasani, Nastaran Khdakarim, Seyed Mehdi Marashi, Shana Ahadi, Parnian Nayebzadeh, Amir Khanmirzaei

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-024-03671-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Akhtar Adereh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Yasuj University of Medical Science, Yasuj, Iran. Hauptthemen laut MEDLINE: MicroRNAs, Mouth Neoplasms, MAP Kinase Signaling System, ras Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral squamous cell carcinoma (OSCC) is a prevalent and aggressive form of head and neck cancer. Emerging evidence suggests that microRNAs (miRNAs) play a crucial role in the development and progression of OSCC. In particular, miR-21 has been implicated in various cellular processes, including proliferation, apoptosis, and invasion; it could be a potential therapeutic target for OSCC. In this study, The Cancer Genome Atlas (TCGA) for OSCC (TCGA-OSCC) clinical information was used. Patient outcomes were analyzed through survival analysis using Kaplan-Meier curves and log-rank tests. The HSC-3cell line was used as the OSCC cell line, which is known for its aggressive characteristics. The expression of Loc646329, miR-21, PTEN, PDCD4, and SPRY2 was evaluated by RT-PCR, flow cytometry, and scratch assay. Also, the effect of Loc646329 expression on OSCC was evaluated using the in vivo Xenograft Mouse Model. The results showed that overexpression of Loc646329 leads to the downregulation of miR-21, PDCD4, and SPRY2 genes while the PTEN gene is upregulated. In other words, the overexpression of Loc646329 by miR-21 inhibition (thorough targeting RAS/MAPK pathway) induces apoptosis and stops the cell cycle in OSCC cells. In vivo tests showed that elevated Loc646329 expression was linked to positive pathological outcomes, such as smaller tumor size, reduced lymph node metastasis, and enhanced overall survival in OSCC patients. In conclusion, the identification of Loc646329 as a sponge for miR-21 and its impact on the RAS/MAPK signaling pathway offers new opportunities for the development of innovative therapeutic strategies for OSCC. Further investigations into this regulatory axis may uncover additional targets for precision medicine approaches in the treatment of OSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMouth NeoplasmsMAP Kinase Signaling Systemras ProteinsSquamous Cell Carcinoma of Head and NeckCarcinoma, Squamous CellHumansAnimalsCell Line, TumorApoptosis Regulatory ProteinsPTEN PhosphohydrolaseMice, NudeMaleFemaleMiceCell ProliferationRNA-Binding ProteinsApoptosisMembrane ProteinsGene Expression Regulation, NeoplasticIntracellular Signaling Peptides and ProteinsMice, Inbred BALB CMiddle Aged

Stichwörter der Autor:innen

Loc646329MAP kinaseMiR-21Oral cancerPTENSPRY2

Substanzen

MicroRNAsMIRN21 microRNA, humanApoptosis Regulatory ProteinsPDCD4 protein, humanPTEN Phosphohydrolaseras ProteinsPTEN protein, humanRNA-Binding ProteinsSPRY2 protein, humanMembrane Proteins

Autor:innen und Institutionen

  • Yasuj University of Medical Science, Yasuj, Iran.
  • Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Department of Cardiology, Internal Medicine, The first affiliated Hospital of Xi'an Jiaotong University, Xian, Shaanxi Province, 710061, China.
  • Assistant Professor of Hematology & Oncology, Department of Internal Medicine, School of Medicine, Hazrat-E Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Tehran University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Adereh, A., Amini, P., Fateh, A., Faghihkhorasani, F., Khdakarim, N., Marashi, S. M., Ahadi, S., Nayebzadeh, P., & Khanmirzaei, A. (2025). Loc646329 sponges miR-21 to reduce RAS/MAP kinase signaling pathway in oral squamous cell carcinoma (OSCC). Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03671-x

Vancouver

Adereh A, Amini P, Fateh A, Faghihkhorasani F, Khdakarim N, Marashi SM, et al. Loc646329 sponges miR-21 to reduce RAS/MAP kinase signaling pathway in oral squamous cell carcinoma (OSCC). Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03671-x

BibTeX
@article{Adereh2025,
  author = {Adereh, Akhtar and Amini, Parya and Fateh, Azadeh and Faghihkhorasani, Ferdos and Khdakarim, Nastaran and Marashi, Seyed Mehdi and Ahadi, Shana and Nayebzadeh, Parnian and Khanmirzaei, Amir},
  title = {Loc646329 sponges miR-21 to reduce RAS/MAP kinase signaling pathway in oral squamous cell carcinoma (OSCC)},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-024-03671-x}
}
Kostenlos starten →